Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading
-
Business12 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
General22 hours agoZoe Daniel calls for election recount in Goldstein after final count gives Liberal Party’s Tim Wilson 260-vote lead
-
Noosa News22 hours ago‘Stranded’ Eddie the echidna thought to have swum from Bribie Island’s broken tip
-
Business12 hours agoAre your superannuation fees too high? APRA reveals latest industry medians